Nevirapine toxicity in a cohort of HIV-1-infected pregnant women

被引:28
|
作者
Joäo, EC
Calvet, GA
Menezes, JA
D'Ippolito, MM
Cruz, MLS
Salgado, LAT
Matos, HJ
机构
[1] Hosp Serv Estado, Dept Infect Dis, BR-20221903 Rio De Janeiro, Brazil
[2] Hosp Serv Estado, Dept Obstet, Rio De Janeiro, Brazil
[3] Hosp Serv Estado, Dept Epidemiol, Rio De Janeiro, Brazil
关键词
nevirapine; toxicity; pregnancy; HIV; HCV;
D O I
10.1016/j.ajog.2005.05.015
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to complete an evaluation of nevirapine (NVP) toxicity in a cohort of HIV+ pregnant women. Study design: This was a retrospective study of 611 women followed from January 1996 to December 2003. All women who used NVP for >7 days were included. Multivariate logistic regression was used to test independent association of CD4 and hepatitis C virus (HCV) infection related to the outcome of toxic effects of NVP. Results: One hundred ninety-seven women were exposed to NVP for > 7 days, and toxicity occurred in 11 (5.6%), leading to drug discontinuation in 7 patients. One case of Stevens-Johnson syndrome Occurred. NO Serious liver toxicity occurred except for I grade 4 cholestasis. Median CD4 was 344 in women without toxicities and 298 in women with toxicities. HCV was the only significant factor associated to toxicity by logistic regression (odds ratio [OR] 15.61, P =.001). Conclusion: NVP toxicities occurred in a very small fraction of patients and were not associated with fatalities. (c) 2006 Mosby, Inc. All rights reserved.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 50 条
  • [41] Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients
    Reliquet, V
    Ferré, V
    Hascoet, C
    Besnier, JM
    Bellein, V
    Arvieux, C
    Molina, JM
    Breux, JP
    Zucman, D
    Rozenbaum, W
    Allavena, C
    Raffi, F
    [J]. ANTIVIRAL THERAPY, 1999, 4 : 83 - 84
  • [42] Population pharmacokinetics of nevirapine in HIV-1 infected Pregnant women and their neonates (TEmAA - ANRS 12109)
    Benaboud, S.
    Ekouevi, D.
    Urien, S.
    Rey, E.
    Arrive, E.
    Blanche, S.
    Gray, G.
    Sim, K. Leang
    Treluyer, J. M.
    Hirt, D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 50 - 50
  • [43] Safety and pharmacokinetics (PK) of nevirapine (NVP) in HIV-1 infected pregnant women and their newborns.
    Mirochnick, M
    Sullivan, J
    Cort, S
    McNamara, J
    Fenton, T
    Sperling, R
    [J]. PEDIATRIC RESEARCH, 1996, 39 (04) : 444 - 444
  • [44] Neurosyphilis in a clinical cohort of HIV-1-infected patients
    Chanem, Khalil G.
    Moore, Richard D.
    Rompalo, Anne M.
    Erbelding, Emily J.
    Zenilman, Jonathan M.
    Gebo, Kelly A.
    [J]. AIDS, 2008, 22 (10) : 1145 - 1151
  • [45] Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission
    Cooper, ER
    Charurat, M
    Mofenson, L
    Hanson, IC
    Pitt, J
    Diaz, C
    Hayani, K
    Handelsman, E
    Smeriglio, V
    Hoff, R
    Blattner, W
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (05) : 484 - 494
  • [46] Streptococcus agalactiae colonization among HIV-1-infected pregnant women -: Antimicrobial susceptibility evaluation
    El Beitune, Patricia
    Duarte, Geraldo
    Leite Maffei, Claudia Maria
    Da Fonseca, Carol Kobori
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (02) : 246 - 246
  • [47] HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes
    Benhammou, Valerie
    Tubiana, Roland
    Matheron, Sophie
    Sellier, Pierre
    Mandelbrot, Laurent
    Le Chenadec, Jerome
    Marel, Emmanuelle
    Khoshnood, Babak
    Warszawski, Josiane
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 77 (05) : 439 - 450
  • [48] Cervical dysplasia on cervicovaginal Papanicolaou smear among HIV-1-infected pregnant and nonpregnant women
    Stratton, P
    Gupta, P
    Riester, K
    Fox, H
    Zorrilla, C
    Tuomala, R
    Eriksen, N
    Vajaranant, M
    Minkoff, H
    Fowler, MG
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (03) : 300 - 307
  • [49] Raltegravir in HIV-1-infected pregnant women: MTCT prophylaxis and children safety case series
    Medeiros, Melissa Soares
    Moreira, Henrique Pires
    Gomes Arruda, Erico Antonio
    Correa, Eduardo Austregesilo
    de Sales, Yasmin Camelo
    Diogenes Teixeira, Gisele Facanha
    Ribeiro, Ederson Aragao
    Dantas, Raquel Silveira
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [50] THE EUROPEAN COLLABORATIVE STUDY - CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF HIV-1-INFECTED PREGNANT-WOMEN
    THORNE, C
    NEWELL, ML
    DUNN, D
    PECKHAM, C
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (11): : 869 - 875